...
首页> 外文期刊>Oral oncology >Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study.
【24h】

Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study.

机译:在用双膦酸盐治疗的骨转移患者中,油悬浮液中用于治疗颌骨坏死的医用臭氧(O(3))的功效和安全性:I-II期研究的初步结果。

获取原文
获取原文并翻译 | 示例
           

摘要

Osteonecrosis of the jaw (ONJ) is an adverse event that has been reported in patients receiving cancer treatment regimens, including bevacizumab, bisphosphonates, and denosumab. We performed a preliminary open label, prospective phase I-II study in patients treated with bisphosphonate to evaluate the treatment effect and tolerability of medical ozone (O(3)) delivered in an oil suspension on BONJ lesions
机译:颌骨坏死(ONJ)是一种不良事件,已在接受包括贝伐单抗,双膦酸盐和地诺单抗在内的癌症治疗方案的患者中报告。我们对双膦酸盐治疗的患者进行了初步的开放标签,前瞻性I-II期研究,以评估油悬液中递送的医用臭氧(O(3))对BONJ病变

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号